Mortality rates in elderly patients who take different angiotensin-converting enzyme inhibitors after acute myocardial infarction: a class effect?

@article{Pilote2004MortalityRI,
  title={Mortality rates in elderly patients who take different angiotensin-converting enzyme inhibitors after acute myocardial infarction: a class effect?},
  author={Louise Pilote and Michal Abrahamowicz and Eric J Rodrigues and Mark J. Eisenberg and Elham Rahme},
  journal={Annals of internal medicine},
  year={2004},
  volume={141 2},
  pages={102-12}
}
BACKGROUND Several randomized, controlled trials show that angiotensin-converting enzyme (ACE) inhibitors improve survival in patients who have had an acute myocardial infarction. However, existing data from trials do not address whether all ACE inhibitors benefit patients similarly. OBJECTIVE To evaluate whether all ACE inhibitors are associated with similar mortality in patients 65 years of age or older who have had an acute myocardial infarction. DESIGN Retrospective cohort study that… CONTINUE READING